David L McKinzie Selected Research

David L McKinzie Research Topics

Disease

10	Schizophrenia (Dementia Praecox) 12/2015 - 11/2003
5	Alzheimer Disease (Alzheimer's Disease) 12/2022 - 09/2010
5	Psychotic Disorders (Schizoaffective Disorder) 12/2013 - 04/2005
4	Mental Disorders (Mental Disorder) 07/2007 - 04/2005
2	Inflammation (Inflammations) 01/2023 - 12/2016
2	Chronic Pain 07/2018 - 12/2016
2	Pain (Aches) 12/2016 - 03/2013
2	Neurobehavioral Manifestations 10/2015 - 01/2012
2	Cognitive Dysfunction 09/2010 - 03/2005
2	Tremor (Tremors) 04/2003 - 04/2003
2	Hypothermia 04/2003 - 04/2003
1	Shock 01/2023
1	Body Weight (Weight, Body) 01/2023
1	Neoplasms (Cancer) 01/2023
1	Acute Radiation Syndrome 01/2023
1	Frailty 01/2023
1	Lymphoma (Lymphomas) 01/2023
1	Progressive Supranuclear Palsy (Steele Richardson Olszewski Syndrome) 12/2022
1	Tauopathies 12/2022
1	Substance Withdrawal Syndrome (Withdrawal Symptoms) 01/2022
1	Opioid-Related Disorders (Opiate Addiction) 01/2022
1	Neuralgia (Stump Neuralgia) 12/2016
1	Mydriasis 10/2014
1	Miosis 10/2014
1	Pathologic Processes 03/2012
1	Anxiety Disorders (Anxiety Disorder) 12/2005
1	Cocaine-Related Disorders (Cocaine Addiction) 10/2003
1	Bradycardia 04/2003
1	Seizures (Absence Seizure) 04/2003

Drug/Important Bio-Agent (IBA)

6	Glutamic Acid (Glutamate)FDA Link 12/2015 - 04/2005
5	Cholinergic Agents (Cholinergics)IBA 10/2015 - 04/2003
5	Muscarinic Receptors (Muscarinic Acetylcholine Receptor)IBA 12/2013 - 04/2003
4	Antipsychotic Agents (Antipsychotics)IBA 12/2015 - 04/2007
3	Muscarinic AgonistsIBA 03/2005 - 04/2003
2	EnzymesIBA 01/2022 - 01/2021
2	Muscarinic M1 ReceptorIBA 10/2015 - 04/2003
2	xanomelineIBA 01/2012 - 08/2008
2	4- aminho- 2- thiabicyclo(3.1.0)hexane- 4,6- dicarboxylic acidIBA 07/2007 - 04/2007
2	LY 379268IBA 04/2007 - 02/2006
2	HexanesIBA 04/2007 - 02/2006
2	eglumetadIBA 04/2007 - 02/2006
1	Urea (Carbamide)FDA LinkGeneric 01/2023
1	Prostaglandins EIBA 01/2023
1	NitrogenIBA 01/2023
1	Dinoprostone (PGE2)FDA Link 01/2023
1	Proteins (Proteins, Gene)FDA Link 12/2022
1	Opioid Analgesics (Opioids)IBA 01/2022
1	Amyloid beta-Protein Precursor (Amyloid Protein Precursor)IBA 01/2022
1	Amyloid beta-PeptidesIBA 01/2021
1	Sucrose (Saccharose)IBA 12/2016
1	Freund's AdjuvantIBA 12/2016
1	Risperidone (Risperdal Consta)FDA LinkGeneric 12/2015
1	pomaglumetad methionilIBA 12/2015
1	Naltrexone (ReVia)FDA LinkGeneric 10/2014
1	Naloxone (Narcan)FDA LinkGeneric 10/2014
1	Morphine (MS Contin)FDA LinkGeneric 10/2014
1	Fentanyl (Sublimaze)FDA LinkGeneric 10/2014
1	Narcotic Antagonists (Opioid Antagonists)IBA 10/2014
1	AticaprantIBA 10/2014
1	mu Opioid Receptors (mu Opioid Receptor)IBA 10/2014
1	Formaldehyde (Formol)FDA Link 03/2013
1	N-dodecyl-L-lysine amideIBA 03/2013
1	Analgesics (Analgesic Drugs)IBA 03/2013
1	Metabotropic Glutamate Receptors (Metabotropic Glutamate Receptor)IBA 03/2012
1	LY 2140023IBA 03/2012
1	Neurotransmitter Agents (Neurotransmitter)IBA 03/2012
1	Phencyclidine (Angel Dust)IBA 09/2010
1	(2- (6- fluoro- 1H- indol- 3- yl)- ethyl)- (3- (2,2,3,3- tetrafluoropropoxy)benzyl)amineIBA 09/2010
1	8- (4- methylpiperazin- 1- yl)- 3- phenylsulfonylquinolineIBA 09/2010
1	Acetylcholine (Acetylcholine Chloride)FDA Link 08/2008
1	Anti-Anxiety Agents (Anxiolytics)IBA 04/2007
1	2- ((2'- amino)propionyl)aminobicyclo(3.1.0)hexane- 2,6- dicarboxylic acidIBA 02/2006
1	AcidsIBA 02/2006
1	ProdrugsIBA 02/2006
1	SulfonamidesIBA 04/2005
1	diphenyl (biphenyl)IBA 04/2005
1	Serotonin Receptor Agonists (Serotonin Receptor Agonist)IBA 11/2003
1	Dopamine Agents (Dopaminergic Agents)IBA 11/2003
1	Lysergic Acid Diethylamide (LSD)IBA 11/2003
1	Dextroamphetamine (Dexedrine)FDA LinkGeneric 11/2003
1	OxotremorineIBA 04/2003
1	ParasympathomimeticsIBA 04/2003
1	Pilocarpine (Ocusert)FDA LinkGeneric 04/2003
1	Phosphatidylinositols (Phosphatidylinositol)IBA 04/2003

Therapy/Procedure

2	Ligation 07/2018 - 12/2016
2	Drug Therapy (Chemotherapy) 12/2015 - 09/2010
1	Analgesia 01/2022
1	Induced Hyperthermia (Thermotherapy) 12/2005